Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04468334 · ClinicalTrials.gov registry record · NA
aMAZE Trial Continued Access Protocol
A NA study, sponsored by AtriCure.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT04468334 is a NA study that has completed, run by AtriCure. The registered enrollment target is 82 participants.
The verdict
NCT04468334, a NA study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
aMAZE CAP is an extension to the current aMAZE Trial investigation (IDEG150107/NCT02517397/Protocol Appendix 16) in the form of a nested, non-randomized registry, to allow ongoing treatment of subjects and the collection of additional safety and effectiveness data at existing aMAZE investigational sites.
Interventions
- DEVICE LARIAT + PVI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2020-03-09 |
| Est. Completion | 2023-04-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04468334
The ClinicalTrials.gov registry entry for NCT04468334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LARIAT + PVI is the first listed.
NCT04468334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04468334 about?
NCT04468334 is a clinical study titled "aMAZE Trial Continued Access Protocol". aMAZE CAP is an extension to the current aMAZE Trial investigation (IDEG150107/NCT02517397/Protocol Appendix 16) in the form of a nested, non-randomized registry, to allow ongoing treatment of subjects and the collection of additional safety and effectiveness data at existing aMAZE investigational s...
What is the current status of trial NCT04468334?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2020-03-09. Estimated completion is 2023-04-24.
What interventions are being tested in trial NCT04468334?
The interventions under investigation include: LARIAT + PVI (DEVICE).
Who is sponsoring clinical trial NCT04468334?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.